Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ALZ-801
ALZ-801
Alzheimer's biotech Alzheon nets $50M Series D
Endpoints
Thu, 04/14/22 - 10:53 am
Alzheon
funding
Alzheimer's disease
ALZ-801
'Very over sold': Biotech brags about PhII Alzheimer's data, but experts are underwhelmed
Endpoints
Wed, 02/9/22 - 10:11 am
Alzheon
Alzheimer's disease
ALZ-801
clinical trials
New Drug Approval Could Be on Horizon for Alzheimer’s after 17-Year Drought
BioSpace
Tue, 03/9/21 - 09:53 pm
Alzheon
Alzheimer's disease
ALZ-801
Alzheon returns, with a $47 million NIH grant and one last shot at a pivotal PhIII Alzheimer’s success
Endpoints
Thu, 08/20/20 - 10:43 am
Alzheon
NIH
grants
Alzheimer's disease
ALZ-801
Alzheon hits another dead end funding its Alzheimer's program, pulls second IPO attempt
Endpoints
Thu, 01/17/19 - 09:42 am
Alzheon
IPOs
clinical trials
ALZ-801
Alzheimer's disease
Alzheon steps back from an IPO, further than ever from a PhIII Alzheimer’s study
Endpoints
Sat, 04/28/18 - 11:47 am
Alzheon
Alzheimer's disease
clinical trials
ALZ-801
IPOs
Alzheon Files for IPO to Fund Studies of Amyloid Alzheimer’s Drug
Xconomy
Sun, 03/18/18 - 11:30 am
Alzheon
Alzheimer's disease
IPOs
ALZ-801
New data from Alzheon shows long-term benefit for Alzheimer's
BioPharma Dive
Tue, 07/18/17 - 11:33 am
Alzheon
Alzheimer's disease
ALZ-801
Little Alzheon looks to raise $100M for a “derisked” Alzheimer’s PhIII
Endpoints
Mon, 07/25/16 - 10:54 am
Alzheon
Alzheimer's disease
ALZ-801
A small biotech in a daunting field, Alzheon begins new Alzheimer’s study
Bizjournals.com
Fri, 11/6/15 - 10:40 am
Alzheon
Alzheimer's disease
ALZ-801